Pat Cotroneo is a seasoned life sciences financial executive who spent over two decades at FibroGen, Inc. (now Kyntra Bio), serving as Chief Financial Officer from 2008 to 2021. During his tenure, he guided FibroGen through two defining transformations: its landmark 2014 IPO - the largest biotech public offering in 12 years - and its evolution into a commercial-stage company with the launch of roxadustat in China in 2019. With 25+ years of senior financial leadership in life sciences, Cotroneo built his career at Deloitte & Touche, SyStemix (a Novartis subsidiary), and ultimately FibroGen, where he oversaw finance, accounting, human resources, and information technology before transitioning to Executive Advisor to the CEO.
Stacey Paynter is the founder and CEO of Strategic Connections, LLC, a San Francisco Bay Area strategic planning and brand consultancy she launched in 2004 after a career spanning some of the largest names in global advertising. As former CEO of Publicis Dialog's San Francisco office and COO of EvansGroup, she co-authored the 'Holistic Communications' framework later adopted worldwide by Publicis Groupe. Today she advises C-suite executives on brand strategy, customer acquisition, and operational transformation — and serves on the board of the OSET Institute as a Brand, PR & Media Advisor.